Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Combination Therapy With Nivolumab (Anti-Pd-1 Monoclonal Antibody): A New Era in Tumor Immunotherapy
Hamed Fooladseresht
Hamed Fooladseresht

Assistant Professor of Immunology

Department of Immunology, School of Medicine

Isfahan University of Medical Sciences

All Documents